Zolmitriptan Nasal Spray for Migraine

Pediatric patients between 6 to 11 years old who have been diagnosed with migraines may be eligible to participate if:

• They have migraines occurring at least 2 times per month with each episode lasting at least 3 hours.
• They experience at least 16 headache-free days per month on average.

Patients are not eligible to participate if:

• They had not experienced satisfactory relief from migraine pain during prior treatment with 2 or more adequate courses of triptans
• They have previously used any nasal spray (triptan or dihydroergotamine) for the acute treatment of migraine
• They have a disease or medical condition which would exclude them from the study.

IMPAX Laboratories, Inc.

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org